MCID: CMP002
MIFTS: 50

Campylobacteriosis

Categories: Gastrointestinal diseases, Infectious diseases

Aliases & Classifications for Campylobacteriosis

MalaCards integrated aliases for Campylobacteriosis:

Name: Campylobacteriosis 12 74 15 17
Enteric Campylobacteriosis 71
Campylobacter Infections 44
Campylobacter Infection 71

Classifications:



External Ids:

Disease Ontology 12 DOID:13622
MeSH 44 D002169
SNOMED-CT 67 86500004
UMLS 71 C0006818 C0275982

Summaries for Campylobacteriosis

Disease Ontology : 12 A primary bacterial infectious disease that results in infection located in intestine, has material basis in Campylobacter jejuni, which is transmitted by ingestion of contaminated food or water or transmitted by contact with infected people or animals. The infection has symptom diarrhea or has symptom dysentery, has symptom abdominal cramps and pain, and has symptom fever.

MalaCards based summary : Campylobacteriosis, also known as enteric campylobacteriosis, is related to enterocolitis and gastroenteritis, and has symptoms including fever, diarrhea and abdominal cramps. An important gene associated with Campylobacteriosis is TLR4 (Toll Like Receptor 4), and among its related pathways/superpathways are Toll-like Receptor Signaling Pathway and Allograft rejection. The drugs Rifaximin and Azithromycin have been mentioned in the context of this disorder. Affiliated tissues include intestine, bone and skin, and related phenotypes are hematopoietic system and cardiovascular system

Wikipedia : 74 Campylobacteriosis is an infection by the Campylobacter bacterium, most commonly C. jejuni. It is among... more...

Related Diseases for Campylobacteriosis

Diseases related to Campylobacteriosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 292)
# Related Disease Score Top Affiliating Genes
1 enterocolitis 30.5 TLR4 IL10
2 gastroenteritis 30.4 IL23A IL1B IL10 IFNG
3 plague 30.0 TLR4 IL1B IL10
4 brucellosis 30.0 TLR4 SLC11A1 IL10 IFNG
5 diarrhea 30.0 TLR4 IL1B IL10 IFNG
6 shigellosis 30.0 TLR4 IL1B IL10
7 irritable bowel syndrome 29.8 TLR4 IL1B IL10
8 salmonellosis 29.7 VDR TLR4 STAT1 SLC11A1 JUN IL1B
9 peritonitis 29.7 TLR4 IL1B IL10
10 myocarditis 29.7 TLR4 IL1B IL10 IFNG
11 hepatitis a 29.6 TLR4 IL1B IL10 IFNG
12 erythema nodosum 29.6 VDR IL1B IL10 IFNG
13 typhoid fever 29.6 TLR4 SLC11A1 IL1B IFNG HTRA1
14 acquired immunodeficiency syndrome 29.5 IL1B IL10 IFNG
15 q fever 29.5 TLR4 SLC11A1 IL1B IL10 IFNG
16 toxoplasmosis 29.4 TLR4 STAT1 IL1B IL10 IFNG
17 thrombocytopenia 29.2 TLR4 STAT1 IL1B IL10 IFNG
18 bacterial infectious disease 29.0 TLR4 SLC11A1 IL1B IL10 IFNG HSPD1
19 disease by infectious agent 29.0 TLR4 SLC11A1 IL23A IL1B IL10 IFNG
20 reactive arthritis 29.0 TLR4 SLC11A1 IL23A IL1B IL10 IFNG
21 chlamydia 28.8 TLR4 IL1B IL10 IFNG HTRA1 HSPD1
22 inflammatory bowel disease 27.7 VDR TLR4 STAT1 SLC11A1 JUN IL23A
23 guillain-barre syndrome 10.4
24 prosthetic joint infection 10.4 TLR4 IL1B
25 staphylococcal toxic shock syndrome 10.4 IL1B IFNG
26 congenital cytomegalovirus 10.3 TLR4 IL1B
27 gastrointestinal tularemia 10.3 TLR4 SLC11A1
28 baritosis 10.3 STAT1 IL1B
29 human t-cell leukemia virus type 2 10.3 STAT1 IFNG
30 pemphigoid 10.3 IL1B IFNG
31 immunodeficiency 27a 10.3 STAT1 IFNG
32 silo filler's disease 10.3 TLR4 IL1B
33 pneumonic tularemia 10.3 TLR4 IL1B
34 lung abscess 10.3 IL1B IFNG
35 radial nerve lesion 10.3 VDR SLC11A1
36 trichomoniasis 10.2
37 toxic encephalopathy 10.2 TLR4 JUN IL1B
38 scleral disease 10.2 IL1B IFNG
39 covid-19 10.2 TLR4 STAT1 IL1B
40 brain edema 10.2 JUN IL1B IFNG
41 breast abscess 10.2 ETV5 APEH
42 glanders 10.2 TLR4 HSPD1
43 opportunistic bacterial infectious disease 10.2 IFNG HSPD1
44 nocardiosis 10.2 IFNG HSPD1
45 alopecia 10.2 VDR IL1B IFNG
46 palladium allergic contact dermatitis 10.2 IL1B IL10
47 ostertagiasis 10.2 TLR4 IL10
48 spotted fever rickettsiosis 10.1 IL10 IFNG
49 metal allergy 10.1 TLR4 IL10
50 monocytic leukemia 10.1 TLR4 JUN IL1B IFNG

Comorbidity relations with Campylobacteriosis via Phenotypic Disease Network (PDN):


Hypertension, Essential

Graphical network of the top 20 diseases related to Campylobacteriosis:



Diseases related to Campylobacteriosis

Symptoms & Phenotypes for Campylobacteriosis

Symptoms:

12
  • fever
  • diarrhea
  • abdominal cramps
  • dysentery

UMLS symptoms related to Campylobacteriosis:


fever, pruritus

MGI Mouse Phenotypes related to Campylobacteriosis:

46 (show all 11)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.23 HSPD1 IFNG IL10 IL1B IL23A JUN
2 cardiovascular system MP:0005385 10.19 HSPD1 HTRA1 IFNG IL10 IL1B JUN
3 integument MP:0010771 10.14 APEH HSPD1 IFNG IL10 IL1B IL23A
4 immune system MP:0005387 10.13 IFNG IL10 IL1B IL23A JUN SLC11A1
5 mortality/aging MP:0010768 10.1 ETV5 HSPD1 IFNG IL10 IL1B IL23A
6 digestive/alimentary MP:0005381 10.02 IFNG IL10 IL23A SLC11A1 STAT1 TLR4
7 limbs/digits/tail MP:0005371 9.91 APEH ETV5 IL10 JUN STAT1 TLR4
8 nervous system MP:0003631 9.85 ETV5 HSPD1 IFNG IL10 IL1B JUN
9 neoplasm MP:0002006 9.8 IFNG IL10 IL1B IL23A SLC11A1 STAT1
10 respiratory system MP:0005388 9.5 ETV5 HSPD1 IFNG IL10 JUN STAT1
11 skeleton MP:0005390 9.32 APEH ETV5 HTRA1 IFNG IL10 IL1B

Drugs & Therapeutics for Campylobacteriosis

Drugs for Campylobacteriosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 18)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Rifaximin Approved, Investigational Phase 2, Phase 3 80621-81-4 6436173 46783403
2
Azithromycin Approved Phase 2, Phase 3 83905-01-5 55185 447043
3 Antibiotics, Antitubercular Phase 2, Phase 3
4 Gastrointestinal Agents Phase 2, Phase 3
5 Anti-Bacterial Agents Phase 2, Phase 3
6 Anti-Infective Agents Phase 2, Phase 3
7
Aluminum hydroxide Approved, Investigational Phase 2 21645-51-2
8 Vaccines Phase 2
9 Spirulina Phase 2
10
Aluminum sulfate Approved Phase 1 10043-01-3
11 Immunologic Factors Phase 1
12 Antacids Phase 1
13 Anti-Ulcer Agents Phase 1
14 Adjuvants, Immunologic Phase 1
15
Formaldehyde Approved, Vet_approved 50-00-0 712
16 Disinfectants
17 Ether
18 Cola

Interventional clinical trials:

(show all 12)
# Name Status NCT ID Phase Drugs
1 Double Blind, Placebo-Controlled Trial Assessing the Efficacy of Rifaximin in Preventing Campylobacteriosis in Subjects Challenged With Campylobacter Jejuni Completed NCT02280044 Phase 2, Phase 3
2 Efficacy of Supplemental Protein, Delivered Alone or in Combination With Treatment for Enteric Pathogens, to Prevent Growth Faltering in Bangladeshi Infants Active, not recruiting NCT03683667 Phase 2, Phase 3 Azithromycin Oral Product;Placebos
3 A Randomized, Double-Blind, Placebo Controlled Vaccination-Challenge Study of ACE393 to Determine Efficacy Against the Symptoms of Moderate to Severe Campylobacter Jejuni Infection in Normal Healthy Volunteers Unknown status NCT00859716 Phase 2
4 A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-De-escalation Study of LMN-101in Healthy Volunteers Challenged With Campylobacter Jejuni Not yet recruiting NCT04182490 Phase 2
5 Campylobacter Jejuni Challenge Model Development: Dose Ranging Study Unknown status NCT00434798 Phase 1
6 Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Unknown status NCT01048112 Phase 1
7 Safety and Immunogenicity Evaluation of an Intramuscular Capsule-Conjugate Campylobacter Vaccine (CJCV1) Completed NCT02067676 Phase 1 Alhydrogel®, aluminum hydroxide adjuvant (alum)
8 An Observational Study of the Role of Antibiotics, Inflammation and Changes in Microbiota in the Development of Post-infective Bowel Dysfunction Following Infection With Campylobacter Jejuni or Coli Unknown status NCT02040922
9 Retrospective Study of Bone Infection Due to Campylobacter Spp Completed NCT02884752
10 Diagnosis of Neglected Tropical Diseases (NTDs) in Patients Presenting With Persistent Digestive Disorders (≥2 Weeks) in Côte d'Ivoire, Indonesia, Mali and Nepal Completed NCT02105714
11 Mucosal and Microbiota Changes During Acute Campylobacteriosis Recruiting NCT03223077
12 Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders Active, not recruiting NCT03266068

Search NIH Clinical Center for Campylobacteriosis

Inferred drug relations via UMLS 71 / NDF-RT 51 :


Ciprofloxacin
ERYTHROMYCIN PWDR

Cochrane evidence based reviews: campylobacter infections

Genetic Tests for Campylobacteriosis

Anatomical Context for Campylobacteriosis

The Foundational Model of Anatomy Ontology organs/tissues related to Campylobacteriosis:

19
Intestine

MalaCards organs/tissues related to Campylobacteriosis:

40
Bone, Skin, Breast, Neutrophil, Pituitary

Publications for Campylobacteriosis

Articles related to Campylobacteriosis:

(show top 50) (show all 1434)
# Title Authors PMID Year
1
Construction, expression and purification of a novel CadF-based multiepitope antigen and its immunogenic polyclonal antibody specific to Campylobacter jejuni and Campylobacter coli. 61
33418060 2021
2
Establishment of sentinel surveillance of human clinical campylobacteriosis in Ireland. 61
33428331 2021
3
Genomic and Phenotypic Characterization of Campylobacter fetus subsp. venerealis Strains. 61
33572216 2021
4
Possible reservoirs of thermotolerant Campylobacter at the farm between rearing periods and after the use of enrofloxacin as a therapeutic treatment. 61
33445066 2021
5
Thermal inactivation and kinetic parameters determination of Campylobacter jejuni on chicken skin. 61
33529082 2021
6
Source attributed case-control study of campylobacteriosis in New Zealand. 61
33221520 2021
7
Genomic analysis of the diversity, antimicrobial resistance and virulence potential of clinical Campylobacter jejuni and Campylobacter coli strains from Chile. 61
33606689 2021
8
Approaches to prevent and control Campylobacter spp. colonization in broiler chickens: a review. 61
33242194 2021
9
Quantitative approach to assess the compliance to a performance objective (PO) of Campylobacter jejuni in poultry meat in France. 61
33091756 2021
10
Recency-Weighted Statistical Modeling Approach to Attribute Illnesses Caused by 4 Pathogens to Food Sources Using Outbreak Data, United States. 61
33350919 2021
11
Cross-contamination events of Campylobacter spp. in domestic kitchens associated with consumer handling practices of raw poultry. 61
33277046 2021
12
Rates of fluoroquinolone resistance in domestically acquired Campylobacter jejuni are increasing in people living within a model study location in Canada. 61
32805182 2021
13
Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection. 61
33382951 2021
14
Analysis of Campylobacter jejuni Subtype Distribution in the Chicken Broiler Production Continuum: a Longitudinal Examination To Identify Primary Contamination Points. 61
33158900 2021
15
A cross-sectional study of the prevalence factors associated with fluoroquinolone resistant Campylobacter jejuni in broiler flocks in Canada. 61
33285388 2021
16
Prevalence and Genotyping of Campylobacter jejuni and Campylobacter coli from Ovine Carcasses in New Zealand. 61
32766835 2021
17
Quantitative trait loci and transcriptome signatures associated with avian heritable resistance to Campylobacter. 61
33436657 2021
18
Comparative history of Campylobacter contamination on chicken meat and campylobacteriosis cases in the United States: 1994-2018. 61
33550153 2021
19
Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis. 61
33466708 2021
20
Clinical Characteristics, Risk Factors, and Population Attributable Fraction for Campylobacteriosis in a Nicaraguan Birth Cohort. 61
33534747 2021
21
Prevalence and associated factor of Campylobacter species among less than 5-year-old children in Ethiopia: a systematic review and meta-analysis. 61
33390175 2021
22
A large food-borne outbreak of campylobacteriosis in kindergartens and primary schools in Pescara, Italy, May-June 2018. 61
33475480 2021
23
Prevalence, Antimicrobial Susceptibility, Virulence and Genotyping of Campylobacter jejuni with a Special Reference to the Anti-Virulence Potential of Eugenol and Beta-Resorcylic Acid on Some Multi-Drug Resistant Isolates in Egypt. 61
33375019 2020
24
Sources and transmission routes of campylobacteriosis: A combined analysis of genome and exposure data. 61
33275955 2020
25
Genetic diversity, antimicrobial resistance, and virulence genes of thermophilic Campylobacter isolated from broiler production chain. 61
32514993 2020
26
Campylobacter sp.: Pathogenicity factors and prevention methods-new molecular targets for innovative antivirulence drugs? 61
33185702 2020
27
Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10-/- Mice. 61
33374868 2020
28
Comparison of Campylobacter spp. and flock health indicators of broilers in Iceland. 61
33356064 2020
29
Update on the campylobacter epidemic from chicken meat in New Zealand: The urgent need for an upgraded regulatory response. 61
33319723 2020
30
Comparison of heat-illness associations estimated with different temperature metrics in the Australian Capital Territory, 2006-2016. 61
33155128 2020
31
Campylobacteriosis in the Nordic countries from 2000 to 2015: Trends in time and space. 61
31763953 2020
32
Genotyping and antibiotic resistance patterns of Campylobacter fetus subsp.venerealis from cattle farms in India. 61
32867004 2020
33
Immunization of Chickens with the Enterobactin Conjugate Vaccine Reduced Campylobacter jejuni Colonization in the Intestine. 61
33316999 2020
34
Identification of the first erm(B)-positive Campylobacter jejuni and Campylobacter coli associated with novel multidrug resistance genomic islands in Australia. 61
33010486 2020
35
Effects of Campylobacter fetus on bull sperm quality. 61
32916242 2020
36
Quantification of cross-contamination of Campylobacter jejuni during food preparation in a model kitchen in China. 61
33232459 2020
37
Severe Salmonella spp. or Campylobacter spp. Infection and the Risk of Biliary Tract Cancer: A Population-Based Study. 61
33198229 2020
38
Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study. 61
33255723 2020
39
Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation in Campylobacter coli-Infected Secondary Abiotic IL-10-/- Mice. 61
33261211 2020
40
Microbiota attenuates chicken transmission-exacerbated campylobacteriosis in Il10-/- mice. 61
33257743 2020
41
Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis. 61
32584649 2020
42
Human campylobacteriosis related to cross-contamination during handling of raw chicken meat: Application of quantitative risk assessment to guide intervention scenarios analysis in the Australian context. 61
32645510 2020
43
Reducing Campylobacter jejuni, Enterobacteriaceae, Escherichia coli, and total aerobic bacteria on broiler carcasses using combined ultrasound and steam. 61
33180927 2020
44
Human Campylobacteriosis Cases Traceable to Chicken Meat-Evidence for Disseminated Outbreaks in Finland. 61
33105906 2020
45
Small-scaled association between ambient temperature and campylobacteriosis incidence in Germany. 61
33057048 2020
46
Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity. 61
33020237 2020
47
Molecular determination of genetic diversity among Campylobacter jejuni and Campylobacter coli isolated from milk, water, and meat samples using enterobacterial repetitive intergenic consensus PCR (ERIC-PCR). 61
33133420 2020
48
Assessment of Campylobacter fetus subsp. venerealis molecular diagnosis using clinical samples of bulls. 61
33121492 2020
49
Occurrence of Campylobacter spp. in Swedish calves, common sequence types and antibiotic resistance patterns. 61
33119192 2020
50
Antimicrobial Resistance Profiles and Phylogenetic Analysis of Campylobacter jejuni Strains Isolated in Brazil by Whole Genome Sequencing. 61
33021437 2020

Variations for Campylobacteriosis

Expression for Campylobacteriosis

Search GEO for disease gene expression data for Campylobacteriosis.

Pathways for Campylobacteriosis

Pathways related to Campylobacteriosis according to GeneCards Suite gene sharing:

(show top 50) (show all 52)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.04 TLR4 STAT1 JUN IL1B IL10 IFNG
2
Show member pathways
12.83 STAT1 IL1B IL10 IFNG HSPD1
3
Show member pathways
12.8 TLR4 STAT1 JUN IL1B IFNG
4
Show member pathways
12.61 STAT1 JUN IL1B IFNG
5
Show member pathways
12.56 STAT1 IL23A IL1B IL10 IFNG
6 12.52 STAT1 IL1B IL10 IFNG
7
Show member pathways
12.51 TLR4 STAT1 JUN IL1B IL10 IFNG
8
Show member pathways
12.39 STAT1 IL23A IL10 IFNG
9
Show member pathways
12.25 TEP1 STAT1 IL1B IL10 IFNG
10
Show member pathways
12.25 TLR4 STAT1 JUN IL1B IFNG
11
Show member pathways
12.24 TLR4 STAT1 JUN IL23A IL1B IL10
12 12.23 TLR4 STAT1 JUN IL1B
13
Show member pathways
12.19 TLR4 STAT1 IL1B IFNG
14 12.17 JUN IL1B IL10 HSPD1
15
Show member pathways
12.16 STAT1 JUN IL23A IL1B IL10
16
Show member pathways
12.13 TLR4 STAT1 JUN IL1B IFNG
17
Show member pathways
12.08 TLR4 STAT1 JUN IL1B IL10 IFNG
18 12.06 TLR4 JUN IL1B IL10
19 12.02 STAT1 JUN IL1B IFNG
20
Show member pathways
12 TLR4 STAT1 JUN IL1B
21 11.96 TLR4 IL1B IFNG
22 11.94 STAT1 IL23A IL1B IL10
23 11.91 JUN IL1B IFNG
24 11.88 STAT1 JUN IL1B
25 11.88 TLR4 IL1B IL10 IFNG
26
Show member pathways
11.88 STAT1 JUN IL1B IFNG ETV5
27
Show member pathways
11.84 STAT1 IL1B IFNG
28 11.79 STAT1 JUN IFNG
29 11.77 TLR4 JUN IL23A IL1B IFNG
30 11.76 VDR JUN IL10
31 11.75 IL23A IL1B IL10 IFNG
32
Show member pathways
11.73 TLR4 STAT1 IL23A IL1B IFNG
33 11.71 IL23A IL1B IL10 IFNG
34
Show member pathways
11.66 JUN IL1B IFNG
35 11.62 STAT1 JUN IFNG
36 11.61 TLR4 IL1B HSPD1
37 11.59 JUN IL23A IFNG
38 11.54 TLR4 JUN IL23A IL1B IL10
39 11.52 TLR4 IL1B IFNG
40 11.52 JUN IL1B IFNG
41 11.48 TLR4 IL1B IL10 IFNG
42 11.48 VDR TLR4 STAT1 IL23A IL1B IL10
43 11.41 VDR JUN IL1B IFNG
44 11.39 STAT1 IL1B IFNG
45 11.39 IL1B IL10 IFNG
46 11.35 TLR4 IL1B IL10
47
Show member pathways
11.31 TLR4 STAT1 JUN IL1B IL10 IFNG
48 11.3 IL23A IL1B IFNG
49 11.24 IL1B IL10 IFNG
50 11.21 JUN IFNG ETV5

GO Terms for Campylobacteriosis

Cellular components related to Campylobacteriosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 lipopolysaccharide receptor complex GO:0046696 8.62 TLR4 HSPD1

Biological processes related to Campylobacteriosis according to GeneCards Suite gene sharing:

(show all 33)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of cell proliferation GO:0008284 9.99 STAT1 SHMT2 JUN IL1B IFNG
2 positive regulation of gene expression GO:0010628 9.98 VDR TLR4 SLC11A1 IL1B IFNG
3 positive regulation of transcription by RNA polymerase II GO:0045944 9.97 VDR TLR4 STAT1 SLC11A1 JUN IL23A
4 immune response GO:0006955 9.95 TLR4 SLC11A1 IL23A IL1B IL10 IFNG
5 response to drug GO:0042493 9.93 STAT1 JUN IL10 HSPD1
6 cytokine-mediated signaling pathway GO:0019221 9.92 STAT1 IL23A IL1B IL10
7 positive regulation of tumor necrosis factor production GO:0032760 9.79 TLR4 IL23A IFNG
8 response to organic substance GO:0010033 9.78 JUN IL10 HSPD1
9 defense response to Gram-negative bacterium GO:0050829 9.77 TLR4 SLC11A1 IL23A
10 positive regulation of interleukin-6 production GO:0032755 9.76 TLR4 IL1B IFNG HSPD1
11 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.75 TLR4 IL23A IL1B
12 response to hydrogen peroxide GO:0042542 9.74 STAT1 JUN HSPD1
13 positive regulation of cytokine production GO:0001819 9.73 SLC11A1 IL10 IFNG
14 positive regulation of phagocytosis GO:0050766 9.72 SLC11A1 IL1B IFNG
15 positive regulation of nitric oxide biosynthetic process GO:0045429 9.71 TLR4 IL1B IFNG
16 positive regulation of interleukin-10 production GO:0032733 9.7 TLR4 IL23A HSPD1
17 positive regulation of interferon-alpha production GO:0032727 9.67 TLR4 STAT1 HSPD1
18 positive regulation of glial cell proliferation GO:0060252 9.66 IL1B ETV5
19 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.65 IL1B IFNG
20 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.65 IL1B IL10
21 positive regulation of signaling receptor activity GO:2000273 9.65 IL10 IFNG
22 regulation of interferon-gamma-mediated signaling pathway GO:0060334 9.64 STAT1 IFNG
23 macrophage activation GO:0042116 9.64 TLR4 SLC11A1
24 positive regulation of granulocyte macrophage colony-stimulating factor production GO:0032725 9.63 IL23A IL1B
25 positive regulation of T-helper 1 type immune response GO:0002827 9.62 SLC11A1 IL23A
26 positive regulation of macrophage activation GO:0043032 9.61 TLR4 IL10 HSPD1
27 positive regulation of nitric-oxide synthase biosynthetic process GO:0051770 9.58 TLR4 STAT1 IFNG
28 positive regulation of interleukin-12 production GO:0032735 9.56 TLR4 IL23A IFNG HSPD1
29 positive regulation of inflammatory response GO:0050729 9.55 TLR4 IL23A IL1B IFNG HSPD1
30 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.51 IL1B IFNG
31 positive regulation of MHC class II biosynthetic process GO:0045348 9.5 TLR4 IL10 IFNG
32 response to lipopolysaccharide GO:0032496 9.43 TLR4 SLC11A1 JUN IL1B IL10 HSPD1
33 positive regulation of interferon-gamma production GO:0032729 9.02 TLR4 SLC11A1 IL23A IL1B HSPD1

Molecular functions related to Campylobacteriosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.92 IL23A IL1B IL10 IFNG

Sources for Campylobacteriosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....